Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
Clinical trial NCT00028002 · COMPLETED
Trial details
- NCT number
- NCT00028002
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-31
- Primary completion
- 2009-01-28
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.